E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 919.8 ILS -1.01% Market Closed
Market Cap: 271.5m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note
EPIT
/
Balance Sheet
/
PP&E Net

Epitomee Medical Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epitomee Medical Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
PP&E Net
$4.9m
CAGR 3-Years
99%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
PP&E Net
$46.9m
CAGR 3-Years
45%
CAGR 5-Years
198%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
PP&E Net
$5.8m
CAGR 3-Years
-15%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Inmode Ltd
NASDAQ:INMD
PP&E Net
$11m
CAGR 3-Years
22%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
PP&E Net
$62m
CAGR 3-Years
10%
CAGR 5-Years
38%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
PP&E Net
$3.5m
CAGR 3-Years
124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Epitomee Medical Ltd
Glance View

Market Cap
271.5m ILS
Industry
Health Care

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

EPIT Intrinsic Value
265.28 ILS
Overvaluation 71%
Intrinsic Value
Price
E
What is Intrinsic Value?

See Also

What is Epitomee Medical Ltd's PP&E Net?
PP&E Net
4.9m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's PP&E Net amounts to 4.9m USD.

What is Epitomee Medical Ltd's PP&E Net growth rate?
PP&E Net CAGR 3Y
99%

Over the last year, the PP&E Net growth was -41%. The average annual PP&E Net growth rates for Epitomee Medical Ltd have been 99% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 202,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.